GLENMARK PHARMACEUTICALS LTD. - Glenmark announces Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler in Europe
Download 
|
< Back |
| 23 Oct 2015 | |
| Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Press Release dated October 23, 2015 titled "Glenmark announces Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler in Europe". | |
| View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback